Essential1: Calorie Burn Strawberry Lemonade Flavor Infuser™


Essential1: Calorie Burn Strawberry Lemonade Flavor Infuser™
Zoom
Essential1: Calorie Burn Strawberry Lemonade Flavor Infuser™
SKU# 72620

Summertime flavor with metabolism boosters.


Servings per Box: 21 Price: $16.40
Qty:

Just add a packet to your drinking water for delicious flavor and an extra metabolism boost! Each serving gives you 100 mg of caffeine and 90 mg of EGCG to enhance fat burning and decrease appetite.

Essential1: CalorieBurn helps you break through a weight-loss plateau, and maintain weight in your maintenance phase. During the weight-loss phase, limit your caffeine intake to 300 mg/day, or a total of 3 Essential1: CalorieBurn products (see our FAQ).

Vegetarian, Lactose Free, Kosher Parve

Dextrin, citric acid, lemon juice concentrate, green tea extract, natural and artificial flavor, malic acid, sucralose, caffeine, sugar, red beet powder (color), corn syrup solids, strawberry juice concentrate.

  1. Add 1 packet to bottled water (16.9 fl. oz.) or a tall glass (2 cups).
  2. Mix until blended. Add more or less water to taste.


Sign up to get updates, tips & special offers:

Need to get in touch with us?

Stay connected with Medifast:

Copyright © 2014 Medifast, Inc. All Right Reserved.
Trademarks | Terms | Privacy | Guarantee

Medifast makes no claim that these results are representative of all participants on the Medifast Program. Medifast recommends you consult with a physician before starting a weight-loss program. Individual results will vary. Medifast is the brand recommended by more than 20,000 doctors since 1980. Typical weight loss on the Medifast 5 & 1 Plan® is 2-5 lbs per week for the first two weeks and 1-2 lbs per week thereafter.

Davis, L.M., Coleman, C.D., Kiel, J., Rampolla, J., Hutchisen, T., Ford, L., Andersen, W.S., Hanlon-Mitola, A. (2010). Efficacy of a meal replacement diet compared to a food-based diet after a period of weight loss and weight maintenance: a randomized controlled trial. Nutrition Journal, 9(11). View Study